Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Innovent Provides Update on ctDNA in Predicting Response and Resistance by Anti-PD-1 Therapy in Chinese Relapsed/Refractory Classical Hodgkin Lymphoma 2019-06-04 08:00
1 2 3